Advertisement

Nitroglycerin Shortage Expected to Ease Soon — Physician’s First Watch

Medical News |
March 27, 2014

Nitroglycerin Shortage Expected to Ease Soon

By Kelly Young

A shortage of injectable nitroglycerin — a staple in emergency care for patients with severe heart attacks or congestive heart failure — is expected to ease within the coming weeks, the New York Times reports.

Baxter, one of the drug's manufacturers, was not able to handle increased demand after two other manufacturers stopped producing nitroglycerin. Baxter has had to limit shipments since January, restricting hospitals to 40% of their usual orders. In March, orders were cut even further, to 20%.

Baxter said it expects to return to January shipping levels by the end of this week. Meanwhile, the FDA has sought out overseas suppliers.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement